WebKriya Therapeutics is a privately-held company developing gene therapies for diseases affecting millions of patients, expanding the field of gene therapy beyond rare monogenic … WebLogo Kriya Therapeutics Overview Overview 6 Reviews 14 Jobs -- Salaries 2 Interviews -- Benefits -- Photos View Jobs at Kriya Therapeutics Kriya Therapeutics Overview …
Kriya Therapeutics Company Profile: Valuation & Investors
WebKriya Therapeutics's key executives include Shankar Ramaswamy and 9 others. Shankar Ramaswamy Co-Founder, Chairman, and Chief Executive Officer Roger Jeffs Co-Founder and Vice Chairman Fraser Wright Co-Founder and Chief Scientific Advisor Melissa Rhodes Chief Development Officer Britt Petty Chief Manufacturing Officer Dana Johnson General … WebFulvio Mavilio, PhD. Scientific Advisory Board Member. Cookie. Duration. Description. cookielawinfo-checkbox-analytics. 11 months. This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for … beca mediaset
Kriya Therapeutics - Crunchbase Company Profile & Funding
Web14 mei 2024 · Kriya专注于开发针对影响数百万患者的疾病的基因疗法 ,将基因疗法的领域扩展到罕见的单基因疾病之外。 Kriya旨在设计出合理的一次性基因疗法,在人体组织中持久表达治疗性蛋白质,以达到治疗疾病的目的。 Ramaswamy博士说:“近年来,针对罕见的单基因疾病的基因疗法获得了众多成功。 我们看到了扩大该领域并将 基因治疗应用于高度 … Web16 mei 2024 · $457.63M Investors Count 17 Funding, Valuation & Revenue 5 Fundings Kriya Therapeutics's latest funding round was a Series C for $270M on May 16, 2024. View all funding This profile has not been claimed. You're more than your latest funding, tell our customers your company's story. Submit Your Analyst Briefing Kriya Therapeutics … Web14 jul. 2024 · REDWOOD CITY, Calif. & RESEARCH TRIANGLE PARK, N.C.-- ( BUSINESS WIRE )-- Kriya Therapeutics, Inc., a fully integrated platform company pioneering novel technologies and therapeutics in gene... dj ace slow jam road to gugulethu